Xenon Pharmaceuticals

Xenon Pharmaceuticals

Yahoo Finance • 6 days ago

Insiders Are Buying These 2 ‘Strong Buy’ Stocks With Over 60% Upside

Insider activity can provide investors with useful clues about how corporate leaders view their own companies. Executives and directors have firsthand knowledge of their businesses, making their disclosed stock transactions worth following... Full story

Yahoo Finance • 22 days ago

Company News for Sep 21, 2026

Shares of Steel Dynamics, Inc. (STLD) declined 4.1% after the company issued weaker third-quarter earnings guidance. Xenon Pharmaceuticals Inc.'s (XENE) shares plummeted 30.7% after the company announced that it is temporarily pausing enr... Full story

Yahoo Finance • 25 days ago

Xenon downgraded at Deutsche Bank after pause in depression trials

[Red dollar sign pointing down with arrow, concept of financial loss, market decline and recession, 3d render] Xenon Pharmaceuticals (XENE [https://seekingalpha.com/symbol/XENE]) fell 30% to reach its lowest level since November after the... Full story

Yahoo Finance • 25 days ago

The Biotech Surged 50% On Positive Data In March. Now, It's Almost Gone.

Xenon Pharmaceuticals voluntarily halted enrollment in a handful of studies Friday due to several unexpected side effects. The biotech stock crashed to a six-month low. Continue Reading... Full story

Yahoo Finance • 25 days ago

Premarket movers: Xenon sinks on trial pause, Netflix hit by downgrade

Investing.com - U.S. stock futures edged broadly higher on Friday, following a rally in stocks in the wake of the Federal Reserve's interest rate hike on Wednesday. Still guessing which names to buy? Our AI rebuilds its stock picks at the... Full story

Yahoo Finance • 25 days ago

Stocks making the biggest moves premarket: Netflix, Nucor, Xenon Pharmaceuticals & more

Check out the companies making the biggest moves premarket: Steel Dynamics , Nucor — Shares of both steel producers fell more than 1.5% after they delivered third-quarter earnings guidance that showed weaker-than-expected results compared... Full story

Yahoo Finance • 25 days ago

Biggest stock movers Friday: XENE, NUE, and more

[Stock market activity shows price changes and trading movements in real time] FabrikaCr Stock futures edged up early Friday as easing oil prices and growing confidence in the Fed's inflation strategy extend Wall Street's post-decision ra... Full story

Yahoo Finance • 3 months ago

Why Wall Street Is Growing More Cautious on Biohaven (BHVN)

With EPS growth for the next five years forecasted at 31.63%, Biohaven Ltd. (NYSE:BHVN) is among the 12 Best Quality Stocks to Buy and Hold for the Next Decade. On June 29, BofA downgraded Biohaven Ltd. (NYSE:BHVN) to Underperform from Ne... Full story

Yahoo Finance • 4 months ago

Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

VANCOUVER, British Columbia and BOSTON, MA, May 29, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercializ... Full story

Yahoo Finance • 6 months ago

Merck & Co Inc: A Significant Addition to Eaton Vance Worldwide Health Sciences Fund

This article first appeared on GuruFocus. Exploring the Fund's Strategic Moves in the Healthcare Sector Eaton Vance Worldwide Health Sciences Fund (Trades, Portfolio) recently submitted its N-PORT filing for the first quarter of 2026, re... Full story

Yahoo Finance • 6 months ago

Xenon Presents Azetukalner Phase 3 X-TOLE2 Study Results and 48-Month Long-term Data in Focal Onset Seizures at 2026 AAN Annual Meeting

Azetukalner data show significant reductions in seizure frequency across weekly, monthly and multi-year time pointsX-TOLE2 data featured in Late-breaking Science session show 53.2% reduction in monthly seizure frequency in 25 mg group vs.... Full story

Yahoo Finance • 7 months ago

This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough

On February 17, 2026, Driehaus Capital Management disclosed a buy of Xenon Pharmaceuticals(NASDAQ:XENE), adding 369,577 shares in an estimated $15.52 million trade based on quarterly average pricing. What happened According to an SEC fil... Full story

Yahoo Finance • 7 months ago

Battery Storage Stock Up 50% in a Year Draws New $110M Investment. Here's What You Should Know

Driehaus Capital Management disclosed a significant buy of Eos Energy Enterprises(NASDAQ:EOSE) in its February 17, 2026, SEC filing, adding 7.70 million shares in an estimated $110.72 million trade based on quarterly average pricing. What... Full story

Yahoo Finance • 7 months ago

Bipolar Depression Market Expected to Witness Accelerated Expansion During the Forecast Period (2026-2036) Amid Advancements in Psychiatric Therapies | DelveInsight

The bipolar depression market is anticipated to increase during the forecast period (2026–2036), owing to the rise in the launch of emerging therapies such as Azetukalner (Xenon Pharmaceuticals), Elunetirom (ABX-002) (Autobahn Therapeutics... Full story

Yahoo Finance • 7 months ago

Xenon Pharmaceuticals prices upsized $650M public offering at $57/share

Xenon Pharmaceuticals (XENE [https://seekingalpha.com/symbol/XENE]) announced pricing of its upsized underwritten public offering [https://seekingalpha.com/pr/20432360-xenon-pharmaceuticals-announces-pricing-of-upsized-650_0-million-public... Full story

Yahoo Finance • 7 months ago

Xenon Pharmaceuticals Announces Pricing of Upsized $650.0 Million Public Offering

VANCOUVER, British Columbia and BOSTON, March 10, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercializatio... Full story

Yahoo Finance • 7 months ago

Xenon to Announce Topline Results from Phase 3 X-TOLE2 Study of Azetukalner in Focal Onset Seizures on Monday, March 9, 2026

VANCOUVER, British Columbia and BOSTON, March 08, 2026 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercializatio... Full story

Yahoo Finance • 8 months ago

Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress

On February 13, 2026, Affinity Asset Advisors disclosed a new position in Praxis Precision Medicines(NASDAQ:PRAX), acquiring 185,000 shares in an estimated $54.53 million trade. What happened According to a SEC filing dated February 13,... Full story

Yahoo Finance • 8 months ago

Apogee Stock Jumps 87% in One Year as This Biotech Fund Lifts Stake to $93 Million

On February 13, 2026, Affinity Asset Advisors disclosed a purchase of 61,500 shares of Apogee Therapeutics(NASDAQ:APGE), an estimated $3.87 million trade based on quarterly average pricing. What happened According to an SEC filing dated... Full story

Yahoo Finance • 10 months ago

Xenon Showcases New 48-Month Azetukalner OLE Study Data in Epilepsy at AES 2025

Monthly reductions in seizure frequency of 90.9% among participants treated for ≥48 months in the OLE, with 38% achieving ≥1 year of seizure freedom New X-TOLE OLE data analysis supports the ability to attain and regain extended periods of... Full story